Sales are quantitatively trivial and structurally typical of post-vesting tax-related liquidation. Flush with institutional bullishness (95% analyst buy rating) and a ~$3.7B market cap, this insider activity provides no credible trading signal. No action warranted; monitor any future large-scale C-suite selling or 10b5-1 establishment.
Price Chart
Executive Summary
Two senior insiders at Oruka Therapeutics (CMO & SVP Finance) collectively sold ~$540K of stock on May 15-18, 2026, following derivative exercises. This represents only ~0.015% of the $3.7B market cap — a trivial dollar value relative to company size. Cluster insider SALES are not amplified by cross-filing context but the absolute materiality is negligible, making this a routine liquidity/vesting event rather than an informed signal.
Key Financial Metrics
Key Facts
- CMO Joana Goncalves sold 4,800 shares at $61.56 for $295K on May 15
- SVP Finance Arjun Agarwal sold 4,190 shares at $58.34 for $244K on May 18
- Both sales followed derivative exercises (options/RSAs) — indicative of tax-covering liquidity sales
- Total cluster value $540K = ~0.015% of $3.7B market cap
- No C-suite CEO/CFO participation; both are second-tier executives one level below C-suite
Financial Impact
Cluster sale value of ~$540K represents 0.015% of market cap — well below 0.1% threshold for materiality
Risk Factors
- Potential further insider sales if share price continues to weaken from May highs
- No CEO or CFO participation could suggest management confidence remains intact
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ORKA-1779142117031 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 16d ago | Insider Cluster | $93.55 $89.93 | ▼ −3.87% | ▼ −6.44% | $84.38 (−9.80%) |
Sep 1, 2026 4w ago | Insider Cluster | $91.63 $91.65 | ▼ −0.02% | ▼ −0.98% | $84.38 (+7.91%) |
Aug 28, 2026 5w ago | EFFECT | $91.15 $92.51 | ▼ −1.50% | ▼ −1.39% | $84.38 (+7.42%) |
Aug 17, 2026 6w ago | Insider Cluster | $113.08 $101.82 | ▼ −9.96% | ▼ −9.76% | $84.38 (−25.38%) |
Aug 10, 2026 7w ago | Press Release | $105.14 $112.66 | ▲ +7.15% | ▲ +7.20% | $84.38 (−19.75%) |
Aug 10, 2026 7w ago | 8-K | $105.14 $112.66 | ▲ +7.15% | ▲ +7.20% | $84.38 (−19.75%) |
Aug 9, 2026 7w ago | Institutional Cluster | $105.14 $112.66 | ▲ +7.15% | ▲ +7.20% | $84.38 (−19.75%) |
Jul 15, 2026 11w ago | Insider Cluster | $83.04 $91.95 | ▲ +10.73% | ▲ +12.40% | $84.38 (+1.61%) |
Jul 2, 2026 13w ago | Insider Cluster | $85.21 $88.27 | ▲ +3.59% | ▲ +2.66% | $84.38 (−0.97%) |
Jun 22, 2026 14w ago | Insider Cluster | $83.40 $92.49 | ▲ +10.90% | ▲ +9.89% | $84.38 (+1.18%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access